Free shipping on all orders over $ 500

SCR7

Cat. No. M4807

SCR7 Structure

Synonym: SCR-7

Size Price Availability Quantity
5mg USD 70 In stock
10mg USD 125 In stock
50mg USD 400 In stock
Bulk Inquiry?

Quality Control
Biological Activity

SCR7 inhibits end joining of double strand breaks in diverse cell types resulting in tumour regression by activation of p53 mediated apoptosis.SCR7 blocks Ligase IV-mediated joining by interfering with its DNA binding but not that of T4 DNA Ligase or Ligase I. SCR7 inhibits NHEJ in a Ligase IV-dependent manner within cells, and activates the intrinsic apoptotic pathway. More importantly, SCR7 impedes tumor progression in mouse models and when coadministered with DSB-inducing therapeutic modalities enhances their sensitivity significantly.SCR7 is a new anti cancer molecule having capability to selectively inhibit non-homologous end joining (NHEJ), one of the DNA double strand break (DSB) repair pathways inside the cells.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 334.40
Formula C18H14N4OS
CAS Number 1533426-72-0
Purity >99%
Solubility DMSO
Storage at -20°C
References

Pluronic copolymer encapsulated SCR7 as a potential anticancer agent.
John F, et al. Faraday Discuss. 2015;177:155-61. PMID: 25608025.

Enhanced efficacy of pluronic copolymer micelle encapsulated SCR7 against cancer cell proliferation.
John F, et al. Macromol Biosci. 2015 Apr;15(4):521-34. PMID: 25515310.

An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.
Srivastava M, et al. Cell. 2012 Dec 21;151(7):1474-87. PMID: 23260137.

Related DNA/RNA Synthesis Products
Vidarabine

Vidarabine is an antiviral drug by interfering with the synthesis of viral DNA, used to treat herpes simplex and varicella zoster viruses.

Uridine

Uridine is a nucleoside, contains a uracil attached to a ribose ring via a β-N1-glycosidic bond.

Rifampicin

Rifampin is a DNA-dependent RNA polymerase inhibitor, used to treat a number of bacterial infections.

Mitomycin C

Mitomycin C is an antineoplastic antibiotic by inhibiting DNA synthesis, used to treat different cancers.

Mercaptopurine (6-MP)

Mercaptopurine is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: SCR7, SCR-7 supplier, DNA/RNA Synthesis, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.